Cargando…

Background parenchymal uptake on molecular breast imaging as a breast cancer risk factor: a case-control study

BACKGROUND: Molecular breast imaging (MBI) is a functional test used for supplemental screening of women with mammographically dense breasts. Additionally, MBI depicts variable levels of background parenchymal uptake (BPU) within nonmalignant, dense fibroglandular tissue. We investigated whether BPU...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hruska, Carrie B., Scott, Christopher G., Conners, Amy Lynn, Whaley, Dana H., Rhodes, Deborah J., Carter, Rickey E., O’Connor, Michael K., Hunt, Katie N., Brandt, Kathleen R., Vachon, Celine M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845425/ https://www.ncbi.nlm.nih.gov/pubmed/27113363 http://dx.doi.org/10.1186/s13058-016-0704-6

Ejemplares similares

Quantitative background parenchymal uptake on molecular breast imaging and breast cancer risk: a case-control study
por: Hruska, Carrie B., et al.
Publicado: (2018)

Impact of short-term low-dose tamoxifen on molecular breast imaging background parenchymal uptake: a pilot study
por: Hruska, Carrie B., et al.
Publicado: (2019)

Half-time Tc-99m sestamibi imaging with a direct conversion molecular breast imaging system
por: Hruska, Carrie B, et al.
Publicado: (2014)

Comparison of Tc-99m maraciclatide and Tc-99m sestamibi molecular breast imaging in patients with suspected breast cancer
por: O’Connor, Michael K., et al.
Publicado: (2017)

Background parenchymal enhancement in preoperative breast MRI
por: Kohara, Satoko, et al.
Publicado: (2015)

Analysis of background parenchymal echogenicity on breast ultrasound: Correlation with mammographic breast density and background parenchymal enhancement on magnetic resonance imaging
por: Ko, Kyung Hee, et al.
Publicado: (2017)

Molecular breast imaging detected invasive lobular carcinoma in dense breasts: A case report
por: Samreen, Naziya, et al.
Publicado: (2019)

MRI Texture Analysis of Background Parenchymal Enhancement of the Breast
por: Amano, Yasuo, et al.
Publicado: (2017)

MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer
por: Bennani-Baiti, Barbara, et al.
Publicado: (2016)

Correction: MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer
por: Bennani-Baiti, Barbara, et al.
Publicado: (2016)

Background Parenchymal Enhancement on Breast MRI as a Prognostic Surrogate: Correlation With Breast Cancer Oncotype Dx Score
por: Zhang, Michelle, et al.
Publicado: (2021)

Fibroglandular Tissue and Background Parenchymal Enhancement on Breast MR Imaging Correlates With Breast Cancer
por: Hu, Xiaoxin, et al.
Publicado: (2021)

Improved visualization of breast tissue on a dedicated breast PET system through ergonomic redesign of the imaging table
por: O’Connor, Michael K., et al.
Publicado: (2017)

Breast cancer and background parenchymal enhancement at breast magnetic resonance imaging: a meta-analysis
por: Hu, Na, et al.
Publicado: (2021)

MRI background parenchymal enhancement, breast density and serum hormones in postmenopausal women
por: Brooks, Jennifer D., et al.
Publicado: (2018)

Quantitative assessment of background parenchymal enhancement in breast magnetic resonance images predicts the risk of breast cancer
por: Hu, Xiaoxin, et al.
Publicado: (2016)

Quantitative background parenchymal enhancement to predict recurrence after neoadjuvant chemotherapy for breast cancer
por: Moliere, Sebastien, et al.
Publicado: (2019)

Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study
por: Watt, Gordon P., et al.
Publicado: (2020)

The correlation of background parenchymal enhancement in the contralateral breast with patient and tumor characteristics of MRI-screen detected breast cancers
por: Vreemann, Suzan, et al.
Publicado: (2018)

The association between breast cancer risk factors and background parenchymal enhancement at dynamic contrast-enhanced breast MRI
por: Hellgren, Roxanna, et al.
Publicado: (2020)

Prediction of background parenchymal enhancement on breast MRI using mammography, ultrasonography, and diffusion-weighted imaging
por: Kawamura, Akiko, et al.
Publicado: (2015)

Prophylactic breast irradiation reduces background parenchymal enhancement (BPE) on MRI: A secondary analysis()
por: Ben-David, Merav A., et al.
Publicado: (2019)

Quantitative background parenchymal enhancement and fibro-glandular density at breast MRI: Association with BRCA status
por: Goodburn, Rosie, et al.
Publicado: (2023)

Background Parenchymal Enhancement of the Contralateral Normal Breast: Association with Tumor Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy()
por: Chen, Jeon Hor, et al.
Publicado: (2015)

Breast vibro-acoustography: initial results show promise
por: Alizad, Azra, et al.
Publicado: (2012)

Association of Daily Alcohol Intake, Volumetric Breast Density, and Breast Cancer Risk
por: Rustagi, Alison S, et al.
Publicado: (2021)

Breast vibro-acoustography: initial experience in benign lesions
por: Alizad, Azra, et al.
Publicado: (2014)

Fully automatic classification of breast MRI background parenchymal enhancement using a transfer learning approach
por: Borkowski, Karol, et al.
Publicado: (2020)

Generalizable attention U-Net for segmentation of fibroglandular tissue and background parenchymal enhancement in breast DCE-MRI
por: Nowakowska, Sylwia, et al.
Publicado: (2023)

Correction: Quantitative background parenchymal enhancement and fibro-glandular density at breast MRI: Association with BRCA status
por: Goodburn, Rosie, et al.
Publicado: (2023)

Correlation Between Mammographic Breast Density, Breast Tissue Type in Ultrasonography, Fibroglandular Tissue, and Background Parenchymal Enhancement in Magnetic Resonance Imaging
por: Alikhassi, Afsaneh, et al.
Publicado: (2018)

Association Between Background Parenchymal Enhancement and Pathologic Complete Remission Throughout the Neoadjuvant Chemotherapy in Breast Cancer Patients
por: You, Chao, et al.
Publicado: (2017)

Association between MRI background parenchymal enhancement and lymphovascular invasion and estrogen receptor status in invasive breast cancer
por: Li, Jun, et al.
Publicado: (2019)

Ultrafast Dynamic Contrast-Enhanced Breast MRI: Lesion Conspicuity and Size Assessment according to Background Parenchymal Enhancement
por: Kim, Soo-Yeon, et al.
Publicado: (2020)

Background parenchymal enhancement: behavior during neoadjuvant chemotherapy for breast cancer and relationship with a pathological complete response
por: Teixeira, Sandra Regina Campos, et al.
Publicado: (2020)

Response Predictivity to Neoadjuvant Therapies in Breast Cancer: A Qualitative Analysis of Background Parenchymal Enhancement in DCE-MRI
por: La Forgia, Daniele, et al.
Publicado: (2021)

Automated volumetric breast density measures: differential change between breasts in women with and without breast cancer
por: Brandt, Kathleen R., et al.
Publicado: (2019)

MRI background parenchymal enhancement, breast density and breast cancer risk factors: A cross-sectional study in pre- and post-menopausal women
por: Brooks, Jennifer D., et al.
Publicado: (2022)

Evaluation of breast parenchymal density with QUANTRA software
por: Pahwa, Shivani, et al.
Publicado: (2015)

Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort
por: Vierkant, Robert A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ro7kle52cde2bfkm76c52rido0